Why Financial Analysts in Pharma Should Love Personalized Medicine

Financial analysts have good reason to anticipate the continued growth of personalized medicine. Not only is it affecting patients and physicians but it holds plenty of promise for the pharma industry. General Strategic Development Benefits Personalized medicine encourages more vertical collaboration throughout the industry. It is therefore in the best interest of pharma companies to […]